1-4 of 4
Fabienne McClanahan, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

REDX08608, a Novel, Potent and Selective, Reversible BTK Inhibitor with Efficacy and Equivalent Potency Against Wild-Type and Mutant C481S BTK

Nicolas E. S. Guisot, PhD, Stuart A. Best, PhD, Victoria Wright, PhD, Andrew Thomason, Jennifer A. Woyach, MD, Rose Mantel, Fabienne McClanahan, MD PhD, Valentina Abet, PhD, Diana Castagna, PhD, Peggy Cousin, MSc, Juliette Emmerich, MSc, Kelvin Ho, PhD, James Russell Kelly, MSc, James King-Tours, MSc, Kristina Lyons, MSc, Melanie Muller, PhD, Julienne Refuerzo, Louise Sargent, MSc, Fatima Talab, PhD, Matilda Bingham, PhD, Caroline Phillips, PhD, Richard Armer, PhD
Journal: Blood
Blood (2016) 128 (22): 4399.
https://doi.org/10.1182/blood.V128.22.4399.4399
Published: 2016
Journal Articles

Exploring the Functional Relevance of BTK Beyond Chronic Lymphocytic Leukemia (CLL) Cells: BTK Expression in Non-Malignant Immune Cells of the Microenvironment Mediates CLL Development and Progression In Vivo

Fabienne McClanahan, MD PhD, Sean D. Reiff, Daphne Guinn, PhD, Minh Tran, Larry Beaver, Samantha McWorther, Rose Mantel, Lisa L. Smith, MS, Amy J. Johnson, PhD, John C. Byrd, MD, Jennifer A. Woyach, MD
Journal: Blood
Blood (2016) 128 (22): 352.
https://doi.org/10.1182/blood.V128.22.352.352
Published: 2016
Journal Articles

BRAF V600E Accelerates Disease Progression and Increases Immune Suppression in a Mouse Model of B-Cell Leukemia

Yo-Ting Tsai, MS, Aparna Lakshmanan, PhD, Amy M. Lehman, MAS, Ellen J. Sass, Minh Tran, Fabienne McClanahan, MD PhD, Meixiao Long, MD PhD, Bonnie K. Harrington, DVM, Krista La Perle, DVM, PhD, Vincenzo Coppola, MD, Gerard Lozanski, MD, Natarajan Muthusamy, DVM, PhD, John C. Byrd, MD, Michael R. Grever, MD, David M. Lucas, PhD
Journal: Blood
Blood (2016) 128 (22): 1206.
https://doi.org/10.1182/blood.V128.22.1206.1206
Published: 2016
Journal Articles

Minimal Renal Toxicity after Rituximab DHAP with a Modified Cisplatin Application Scheme in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma

Katharina Lisenko, MD, Fabienne McClanahan, MD PhD, Tilman Schöning, MD, Mark-Alexander Schwarzbich, MD, Martin Cremer, MD, Tobias Dittrich, MD, Anthony D. Ho, MD, Mathias Witzens-Harig, MD
Journal: Blood
Blood (2015) 126 (23): 1506.
https://doi.org/10.1182/blood.V126.23.1506.1506
Published: 2015